浙江省中医院心肌梗死住院患者治疗状况调查分析

A Therapeutic Status Survey of the Hospitalized Patients with Myocardial Infarction in Zhejiang Hospital of Traditional Chinese Medicine

[目的]分析心肌梗死(MI)患者住院治疗状况。[方法]2004年1月至2008年5月心肌梗死患者,对治疗状况进行调查分析。[结果]50.9%的AMI患者行急诊PCI,阿司匹林、氯吡格雷、低分子肝素、ACEI/ARB、他汀类药物、中药的使用情况较好,β受体阻滞剂的使用率偏低。[结论]MI治疗基本上遵循了国际上公认的指南,但β受体阻滞剂使用仍有提升的空间,中药得到了广泛的应用,但其疗效缺乏大量的循证医学证据。

[Objective] Toenalyse the therapies of the hospitalized patients with myocardial infarction（MI）. [Methods] To select the hospitalized patients with myocardial infarction between January 2004 and May 2008 and to investigate the patients, therapies. [Results] 50.9% of the AMI patients received therapy of emergency PCI and the utilization rates of aspirin, clopidogrel, low-mo-lecular-weight heparin, ACEI/ ARB, statins; Chinese medicine was better but the utilization rate of beta-blocker was slightly lower. [Conclusions]The guidelines were implemented in the therapies of myocardial infarction patients, but the use of beta-blocker still could be improved, Chinese medicine was widely used, hut still needed to be proved by evidence-based medicine.